Human medicines
Lasix
In a letter dated April 12, 2011, the marketing authorization holder informed its customers that visible particles had been detected in two batches…
EBEDOCE
In a letter dated March 30, 2011, the marketing authorization holder informed its supplied customers of a precautionary recall, as isolated…
Truxal
The marketing authorization holder informed its supplied customers by letter dated Feb. 21, 2011, that information for use in Norwegian language was…
Vivotif-Kapseln
The marketing authorization holder has informed its supplied customers that results from stability data indicate a possible shortfall of the required…
Fragmin
The marketing authorization holder informed its supplied customers in a letter dated February 3, 2011, that empty or almost empty prefilled syringes…
Pegasys
The marketing authorization holder has informed its supplied customers in a letter dated January 25, 2011, that cracks have been detected in the cone…
Ebixa
The marketing authorization holder, in agreement with the European Medicines Agency (EMA), has informed the wholesalers supplied that all batches with…
Dianeal
Two batches of the product Dianeal have been identified that may contain endotoxins. Therefore, the marketing authorization holder has decided to…
Nutrineal
The marketing authorization holder has received increased adverse reactions (aseptic peritonitis) to the above batch. Therefore, Baxter Healthcare has…
Glucobene tablets
The marketing authorization holder informed its supplied customers in a fax transmission on December 20, 2010, that due to complaints on the German…